| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $4.40B | +3.7% |
| Gross profit | $0.76B | — |
| Operating income | $0.51B | — |
| Net income | $0.33B | -9.6% |
| Gross margin | 17.3% | Net margin 7.5% |
| Segment | Revenue | Share |
|---|---|---|
| US | $1.50B | 34.0% |
| Health | $1.19B | 27.0% |
| Defense | $0.88B | 20.1% |
| Homeland | $0.82B | 18.5% |
| Non Us | $0.00B | 0.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $3.64B | 82.7% |
| SG&A | $0.22B | 5.1% |
| Tax & other | $0.18B | 4.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
LEN ・ LII ・ LLY ・ LIN ・ LYV ・ LMT ・ L ・ LOW ・ LULU ・ LITE ・ LYB ・ MTB
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies